Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jul 27, 2025; 17(7): 106487
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.106487
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.106487
Table 2 Clinical efficacy
Group | CR | PR | SD | PD | ORR | DCR |
Control group (n = 54) | 11 (20.37) | 14 (25.93) | 13 (24.07) | 16 (29.63) | 25 (46.30) | 38 (70.37) |
Observation group (n = 26) | 13 (50.00) | 9 (34.62) | 2 (7.69) | 2 (7.69) | 22 (84.62) | 24 (92.31) |
χ2/t | - | - | - | - | 10.634 | 4.844 |
P value | - | - | - | - | 0.001 | 0.028 |
- Citation: Ma HY, Liu X, Chen YW, Liang J, Wang J, Zhang MM, Yang Q. Baohe Pingwei power plus neoadjuvant chemotherapy for gastric cancer. World J Gastrointest Surg 2025; 17(7): 106487
- URL: https://www.wjgnet.com/1948-9366/full/v17/i7/106487.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i7.106487